Prosecution Insights
Last updated: October 25, 2026

KWS Saat SE & Co. KGaA

Technology area: Biotechnology & Pharmaceuticals

17 pending office actions • 6 art units • 14 examiners • 0 of 17 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days

Analysis

KWS Saat SE & Co. KGaA has 15 pending office actions in Biotechnology & Pharmaceuticals. The matters span 12 distinct examiners and 5 art units, indicating that prosecution is distributed across multiple examination teams rather than centered in one unit.

PAGE, BRENT T is the busiest examiner, with 2 pending actions. That concentration is limited relative to the full docket, so portfolio management should preserve matter-specific review while tracking recurring issues across the broader examiner and art-unit spread.

The distribution creates a need for coordinated claim terminology, disclosure support, and response positions across applications. At the same time, the number of examination contacts may require separate preparation for examiner-specific practice and technical focus.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

17
Total Pending OAs
11
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
2
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (2)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (53%)
3
Medium (18%)
5
Easy (29%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (18%)
§103 only2 (12%)
§112 only5 (29%)
Double-patenting + other1 (6%)
Multi-statute (no §101)6 (35%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

14
Life Sciences
82% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
6% of docket
2
Mechanical / Eng
12% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

170 h
Manual time on pending OAs
34 h
Time saved (low, 20%)
59 h
Time saved (mid, 35%)
1.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAGE, BRENT T 2 82.4% +10.7%
CHATTERJEE, JAYANTA 2 44.0% +70.1%
MCWILLIAMS, KELSEY LYNN 2 89.2% +5.8%
ZHONG, WAYNESHAOBIN 1 72.3% +21.4%
MEADOWS, CHRISTINA L 1 74.3% +25.2%
JOHNSON, EMILY KATHARINE 1 87.5% +21.9%
ZHENG, LI 1 83.5% +13.0%
MARINI, MATTHEW G 1 60.6% +21.9%
WILLIAMS, KEITH RICHARD 1 50.0% +0.0%
SHARMA, SANTOSH 1 72.8% +29.8%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18266884 TARGETED INFLUENCE ON MEIOSIS FOR INCREASING RECOMBINATION FREQUENCY MCWILLIAMS, KELSEY LYNN 15d overdue
18292125 PLANTS WITH IMPROVED DIGESTIBILITY AND MARKER HAPLOTYPES ZHENG, LI —
17776111 GENE FOR RESISTANCE TO A PATHOGEN OF THE GENUS HETERODERA MCWILLIAMS, KELSEY LYNN —
17056043 ARTIFICIAL MARKER ALLELE PAGE, BRENT T —

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18007827 REAL-TIME KINEMATIC (RTK) POSITIONING SYSTEM, BASE STATION AND METHODS FOR CALIBRATING AND OPERATING MULL, FRED H 25d overdue
17783997 ENHANCED DISEASE RESISTANCE OF MAIZE TO NORTHERN CORN LEAF BLIGHT BY A QTL ON CHROMOSOME 4 SWITZER, JULIET CAROLINE 17d overdue
18008731 METHOD AND SYSTEM FOR MANAGING AGRICULTURAL PROCESSES BROWN, SARA GRACE 28d
18779482 HYBRID NUCLEIC ACID SEQUENCES FOR GENOME ENGINEERING PAGE, BRENT T 42d
17768696 ENHANCED DISEASE RESISTANCE OF CROPS BY DOWNREGULATION OF REPRESSOR GENES STOCKDALE, JESSICA NICOLE 79d
19106507 USE OF PAIRED GENES IN HYBRID BREEDING ZHONG, WAYNESHAOBIN —
18816918 GENERATION OF HAPLOID PLANTS MEADOWS, CHRISTINA L —
18687796 PERFORMANCE GAIN IN ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS PLANTS BY COMBINATION OF BEST FITTING ALS LARGE AND SMALL SUBUNITS JOHNSON, EMILY KATHARINE —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18687799 ALS-INHIBITOR HERBICIDE TOLERANT BETA VULGARIS HYBRIDS WITH INCREASED HETEROSIS CHATTERJEE, JAYANTA 12d
18779482 HYBRID NUCLEIC ACID SEQUENCES FOR GENOME ENGINEERING PAGE, BRENT T 42d
18021756 PLANT RESISTANCE GENE AND MEANS FOR ITS IDENTIFICATION CHATTERJEE, JAYANTA 55d
19106507 USE OF PAIRED GENES IN HYBRID BREEDING ZHONG, WAYNESHAOBIN —
18816918 GENERATION OF HAPLOID PLANTS MEADOWS, CHRISTINA L —
18687796 PERFORMANCE GAIN IN ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS PLANTS BY COMBINATION OF BEST FITTING ALS LARGE AND SMALL SUBUNITS JOHNSON, EMILY KATHARINE —
18292125 PLANTS WITH IMPROVED DIGESTIBILITY AND MARKER HAPLOTYPES ZHENG, LI —
18271813 ENRICHED SUGARBEET PULP PRODUCTION MARINI, MATTHEW G —

Top Art Units

Art UnitApps
1663 9
1662 4
2853 1
3625 1
3648 1
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19106507 USE OF PAIRED GENES IN HYBRID BREEDING ZHONG, WAYNESHAOBIN 1662 §103§112 Non-Final OA — Pending Feb 25, 2025
18816918 GENERATION OF HAPLOID PLANTS MEADOWS, CHRISTINA L 1663 §103§112 Non-Final OA — Pending Aug 27, 2024
18779482 HYBRID NUCLEIC ACID SEQUENCES FOR GENOME ENGINEERING PAGE, BRENT T 1663 §102§103§112 Final Rejection 42d Pending Jul 22, 2024
18687796 PERFORMANCE GAIN IN ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS PLANTS BY COMBINATION OF BEST FITTING ALS LARGE AND SMALL SUBUNITS JOHNSON, EMILY KATHARINE 1663 §101§103§112 Non-Final OA — Pending Feb 28, 2024
18687799 ALS-INHIBITOR HERBICIDE TOLERANT BETA VULGARIS HYBRIDS WITH INCREASED HETEROSIS CHATTERJEE, JAYANTA 1662 §103§112DP Final Rejection 12d Pending Feb 28, 2024
18292125 PLANTS WITH IMPROVED DIGESTIBILITY AND MARKER HAPLOTYPES ZHENG, LI 1662 §112 Non-Final OA — Pending Jan 25, 2024
18271813 ENRICHED SUGARBEET PULP PRODUCTION MARINI, MATTHEW G 2853 §103 Non-Final OA — Pending Jul 11, 2023
18266884 TARGETED INFLUENCE ON MEIOSIS FOR INCREASING RECOMBINATION FREQUENCY MCWILLIAMS, KELSEY LYNN 1663 §112 Non-Final OA 15d overdue Pending Jun 13, 2023
18034286 METHODS FOR CEREAL CROP HYBRID TEST CROSS EVALUATION WILLIAMS, KEITH RICHARD 1663 §103§112 Final Rejection — Pending Apr 27, 2023
18033576 USE OF ENHANCED POL THETA ACTIVITY FOR EUKARYOTIC GENOME ENGINEERING SHARMA, SANTOSH 1663 §112 Non-Final OA — Pending Apr 25, 2023
18021756 PLANT RESISTANCE GENE AND MEANS FOR ITS IDENTIFICATION CHATTERJEE, JAYANTA 1662 §112Other Non-Final OA 55d Pending Feb 16, 2023
18008731 METHOD AND SYSTEM FOR MANAGING AGRICULTURAL PROCESSES BROWN, SARA GRACE 3625 §101§103§112 Non-Final OA 28d Pending Dec 07, 2022
18007827 REAL-TIME KINEMATIC (RTK) POSITIONING SYSTEM, BASE STATION AND METHODS FOR CALIBRATING AND OPERATING MULL, FRED H 3648 §103§112 Final Rejection 25d overdue Pending Dec 02, 2022
17783997 ENHANCED DISEASE RESISTANCE OF MAIZE TO NORTHERN CORN LEAF BLIGHT BY A QTL ON CHROMOSOME 4 SWITZER, JULIET CAROLINE 1682 §101§102§112Other Non-Final OA 17d overdue Pending Jun 09, 2022
17776111 GENE FOR RESISTANCE TO A PATHOGEN OF THE GENUS HETERODERA MCWILLIAMS, KELSEY LYNN 1663 §112 Non-Final OA — Pending May 11, 2022
17768696 ENHANCED DISEASE RESISTANCE OF CROPS BY DOWNREGULATION OF REPRESSOR GENES STOCKDALE, JESSICA NICOLE 1663 §102§103§112 Final Rejection 79d Pending Apr 13, 2022
17056043 ARTIFICIAL MARKER ALLELE PAGE, BRENT T 1663 §103 Final Rejection — Pending Nov 17, 2020

Managing KWS Saat SE & Co. KGaA's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does KWS Saat SE & Co. KGaA have?

KWS Saat SE & Co. KGaA has 17 pending office actions as of October 2026, spread across 6 art units and 14 examiners.

Which USPTO examiner handles the most KWS Saat SE & Co. KGaA applications?

Brent T Page has the most, with 2 of KWS Saat SE & Co. KGaA's pending office actions.

What technology area are KWS Saat SE & Co. KGaA's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month